アジェンダ
10:00 AM — 10:40 AM
Welcome, Opening Remarks, and Keynote Address10:40 AM — 10:55 AM
10:55 AM — 12:10 PM
Session 2: Biosimilars During a Pandemic12:10 PM — 12:40 PM
12:40 PM — 1:55 PM
Session 3: Streamlining Biosimilar Clinical Development1:55 PM — 2:20 PM
3:35 PM — 4:05 PM
4:05 PM — 5:20 PM
Session 5: What Will Biosimilars Look Like in Five Years?5:30 PM — 6:15 PM
Reception Round Tables – Market Challenges for Biosimilars11:25 AM — 12:40 PM
Session 7: Prescriber and Patient Confidence with Biosimilar Use12:40 PM — 1:10 PM
1:10 PM — 2:40 PM
Session 8: Stakeholder Voice: Biosimilar Decision Making2:40 PM — 3:00 PM
3:00 PM — 4:30 PM
Session 9: Regulatory Landscape – Ask the Regulators and Closing Remarks4:40 PM — 5:25 PM
Reception Round Tables - Market Challenges for Biosimilars5:25 PM — 5:25 PM